Jupiter Neurosciences shares are trading higher after the company's related biotechnology partner, PharmAla Biotech Holdings, announced a series of corporate updates, including a newly granted U.S. patent.

Jupiter Neurosciences shares are trading higher after the company announced the first patient has been dosed in its Phase 2a RESET clinical trial evaluating JOTROL in patients with Parkinson’s disease.

Jupiter Neurosciences Doses First Participant In Its Phase 2a RESET Clinical Study Of JOTROL To Treat Parkinson's Disease

Jupiter Neurosciences, Inc. (NASDAQ:JUNS), a clinical-stage biopharmaceutical company developing investigational therapies for neurodegenerative diseases, today announced that the first patient has been dosed in the

8-K filing — JUPITER NEUROSCIENCES, INC. (JUNS)

Filed: 2026-09-03 AccNo: 0001493152-26-041315 Size: 212 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

Dow Falls Over 300 Points; SAIC Shares Jump After Upbeat Q2 Results

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Monday. Following the market opening Monday, the Dow traded down 0.61% to 53,232.50 while the NASDAQ slipped 0.45% to

Why Webuy Global Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket

Shares of Webuy Global Ltd (NASDAQ:WBUY) rose sharply in pre-market trading. Webuy reported record preliminary unaudited travel bookings of around $4.76 million during the three-day NATAS Fair in Aug. 2026,

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers Picard Medical (AMEX:PMI) shares moved upwards by 82.7% to $9.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.5 million. As per the news, the Q2 earnings report